Digital device technologies (DDTs), such as wearable gait sensors, voice and video recordings, bear strong potential for monitoring symptoms of chronic and increasingly prevalent diseases, such as Parkinson’s Disease (PD). This could facilitate a more personalized and higher quality treatment in the future. As part of the EU-wide project DIGIPD, we confirmed this potential using data from three different cohort studies in Luxembourg, France and Germany. Data processing using artificial intelligence allows inferring disease symptoms and their progression. We found that DDTs, which collect large amounts of data during use, are highly accepted by patients. There are, however, challenges to legally collect patient-level data and process them using artificial intelligence for research and medical development in the EU. Our panel will discuss this topic from the perspective of physicians, data scientists, patients and lawyers.
